[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2021240331A1 - Process for the preparation of 3,5-dichloro-2,2,2-trifluoroacetophenone - Google Patents

Process for the preparation of 3,5-dichloro-2,2,2-trifluoroacetophenone Download PDF

Info

Publication number
WO2021240331A1
WO2021240331A1 PCT/IB2021/054467 IB2021054467W WO2021240331A1 WO 2021240331 A1 WO2021240331 A1 WO 2021240331A1 IB 2021054467 W IB2021054467 W IB 2021054467W WO 2021240331 A1 WO2021240331 A1 WO 2021240331A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
compound
halide
acid
preparation
Prior art date
Application number
PCT/IB2021/054467
Other languages
French (fr)
Inventor
Sudhir Nambiar
Rakesh Ramesh GANORKAR
Kiran Chaudhari
H.d. GURUPADASWAMY
Sham SHELAR
G.v. RAMESHA
Original Assignee
Hikal Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hikal Limited filed Critical Hikal Limited
Publication of WO2021240331A1 publication Critical patent/WO2021240331A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides

Definitions

  • the present invention relates to an improved process for the preparation of intermediate 3,5- dichloro-2,2,2-trifluoroacetophenone of formula (I).
  • the present invention further provides an improved process for the preparation of Fluralaner using 3,5-dichloro-2,2,2- trifluoroacetophenone of formula (I) obtained by a process described herein.
  • the 3,5-dichloro-2,2,2-trifluoroacetophenone is a key intermediate for preparing veterinary APIs such as Fluralaner, Lotilaner, Afoxolaner.
  • the 3,5-dichloro-2,2,2-trifluoroacetophenone is disclosed in a Journal of Physical Organic Chemistry ,(1989), Vol.2 (4), Pg.363-366, wherein it is synthesized from corresponding aryl halides via. Grignard reaction with trifluoroacetic anhydride at lower temperature (-70°C).
  • the Chinese patent application no. CN107353189; (henceforth ‘189) discloses a method for producing 3,5-dichloro-2,2,2-trifluoroacetophenone by reacting 3,5-dichlorobromobenzene with unstable trifluoroacetic anhydride in presence of expensive tert-butyllithium at -78°C.
  • the above reaction not only involves expensive reagents but also drastic reaction conditions and result into low reaction yield (41%).
  • the ⁇ 89 patent application also disclosed the use of 3,5-dichlorobromobenzene and 1 -trifluoroacetyl piperidine in presence of tert-butyl lithium at -78°C for isolation of 3,5-dichloro-2,2,2-trifluoroacetophenone after high vacuum distillation resulting in low chemical yield (37%).
  • the above reaction involved costly reagents, multiple purifications including high vacuum distillation, thus increases overall cost.
  • the prior-art process(es) involve one or more process steps and/or reasons where the overall production cost increases in the production of an intermediate 3,5-dichloro-2,2,2- trifluoroacetophenone and consequently of Fluralaner.
  • T and Y each independently represent a substituted aryl or a substituted heteroaryl
  • X represents a hydrogen atom or a halogen atom
  • the inventors of instant invention have developed an improved process for the preparation of 3,5-dichloro-2,2,2-trifluoroacetophenone to overcome the limitations of the prior arts in cost effective and industrially convenient way in high yield (70%) in less cycle time with greater chemical purity (99%).
  • the instant two-step process performed on industrial scale by using commercially available key raw materials such as piperidine and 3,5-dichloroaniline.
  • the instant process involve the simple reactions such as Sandmeyer reaction for preparation of 3.5-dichlorobromobenzene from 3,5-dichloroaniline and coupling of 3,5- dichlorobromobenzene with 1 -trifluoroacetyl piperidine in presence of Grignard reagent to obtain 3,5-dichloro-2,2,2-trifluoroacetophenone (I), which is further utilized for the preparation of Fluralaner as disclosed in Nissan’s PCT application WO 2013/021949 A1.
  • the main objective of the present invention is to provide an improved process for the preparation of a 3,5-dichloro-2,2,2-trifluoroacetophenone formula (I) using key raw materials piperidine and 3,5-dichloroaniline.
  • Another objective of the present invention is to provide a process for preparation of 3,5- dichloro-2,2,2-trifluoroacetophenoneformula (I) by reacting compound of formula (II) and compound of formula (IV).
  • Yet another objective of the present invention is to provide an improved process for the preparation of Fluralaner by using 3,5-dichloro-2,2,2-trifluoroacetophenone formula (I) which is obtained by a process of an instant invention.
  • 3.5-dichloro-2,2,2-trifluoroacetophenone of formula (I) which comprises the steps of: a) reacting piperidine andethyl triflu oroacetate to obtain compound of formula (II); b) obtaining compound of formula (I) by reacting compound of formula (II) and compound of formula (IV) with Grignard reagent in presence of solvent, wherein compound of formula (IV) is obtained by preparing a diazonium salt of compound formula (III) in presence of copper halide or potassium halide, acid and aqueous hydrogen bromide; c) optionally, purifying compound of formula (I).
  • compositions comprising, “comprising,” “includes,” “including,” “has,” “having,” “contains” or “containing,” or any other variation thereof, are intended to cover a non-exclusive inclusion.
  • a composition, a mixture, process, method, article, or apparatus that comprises a list of elements is not necessarily limited to only those elements but may include other elements not expressly listed or inherent to such composition, mixture, process, method, article, or apparatus.
  • “or” refers to an inclusive or and not to an exclusive.
  • solvent refers to the single solvent or mixture of solvents.
  • the present invention provides the process for preparation of 3,5-dichloro-2,2,2-trifluoroacetophenone of formula (I), which comprises the step(a) of reacting a piperidine and ethyl triflu oroacetate to obtain compound of formula (II) without using any solvent and reagent (neat reaction).
  • the step (a) is performed at temperature 25 °C to 90°C and for 4-6 hours.
  • step (a) wherein compound of step (a) is obtained by distillation under vacuum of 15 to20 Torr at temperature 80°C to90°C.
  • step (b) wherein compound of formula (I) instep (b) is obtained by reacting a compound of formula (II) with compound of formula (IV) in presence of Grignard reagent in solvent such as tetrahydrofuran; wherein the Grignard reagent is prepared by using suitable alkyl magnesium halide in presence of suitable initiator in suitable solvent or mixture of solvents thereof.
  • solvent such as tetrahydrofuran
  • suitable alkyl magnesium halide is prepared by reacting alkyl halide with magnesium metal in suitable solvents at 10°C to 30°C.
  • suitable alkyl halide is selected from isopropyl bromide, isopropyl chloride, methyl bromide and the like.
  • suitable initiator is Iodine
  • suitable solvents of step (b) is ethereal solvent and hydrocarbon solvent.
  • ethereal solvent is selected from tetrahydrofuran, diethyl ether, dibutyl ether, 2 -methyl tetrahydrofuran, tert -butyl methyl ether and the like; preferably tetrahydrofuran.
  • hydrocarbon solvent is selected from toluene, hexane, and the like.
  • diazonium salt is prepared by reacting 3,5-dichloroaniline of formula (III) with sodium nitrite in a suitable acid; wherein suitable acid is selected from hydrobromic acid, hydrochloric acid, concentrated sulfuric acid, acetic acid and the like; preferably hydrochloric acid.
  • suitable solvent used for preparation of diazonium salt is selected from water, acetonitrile, polyethylene glycol and the like; preferably water.
  • suitable Copper halide is selected from Copper (I) bromide, Copper (I) chloride, Copper (I) iodide and suitable potassium halide is Potassium Iodide.
  • step (c) pure compound (I) is obtained by high vacuum distillation using vacuum of 10-15 torr at 80°C to 90°C.
  • the ethyl trifluoroacetate (1.0 to 1.2eq) was added into piperidine (l.Oeq) at 20°C to 30°C for 1-2 hours.
  • the reaction mixture was heated at 75°C to 85°C and stirred for 3-4 hours. After completion of reaction, the reaction mixture was kept for simple distillation at 90 °C to 100°C for 3-4 hours and further distilled under vacuum of at 80°C to 90°Cto obtain the compound II (90% yield, GC purity: 99.9%).
  • acetonitrile (IV) was charged and stirred at 20°C to 30°C for 15 min.
  • Water (2V) and aqueous hydrobromic acid (3V) were added at 25°C to 35°C.
  • the reaction mixture was cooled to 0°C to 5°C and aqueous sodium nitrite solution (70.26 g, 1.1 eq) was added slowly at 0°C to 5°C within 1-3 hours.
  • the reaction mixture was stirred at 0°C to 5°C for 1 hour.
  • reaction mixture was cooled to 20°C to 30°C and quenched by adding water.
  • the aqueous layer was extracted with dichloromethane and combined organic layer was washed with aqueous sodium bicarbonate and brine solution. The solvent was removed under vacuum to obtain the crude compound IV and the pure compound is obtained by high vacuum distillation (72% yield, HPLC purity: 98%).
  • the magnesium turning (1.0 to 1.4 eq), tetrahydrofuran (IV) and Iodine (0.1 to0.4eq) were charged into a round bottom flask and stirred.
  • a solution of isopropyl bromide (1 to 1.4 eq) in tetrahydrofuran (3V) was added and stirred at 20°C to 30°C for 1-2 hours.
  • the reaction mixture was cooled to 0°C to 5°C and a solution of 3,5- dichlorobromobenzene (IV, l.Oeq) in tetrahydrofuran (2V) was added.
  • the reaction temperature was raised to 0°C to 30°C and stirred for 1 hour.
  • reaction mixture was cooled to 0°C to 5°C and 1-trifluoroacetyl piperidine (II) was added.
  • the reaction temperature was raised to 20°C to 30°C and stirred for 1-2 hours.
  • After completion of reaction the reaction mixture was cooled to 0°C to 5°C and quenched by adding into aqueous hydrochloric acid.
  • the reaction mass temperature was raised to 20°C to 30°C and stirred for 1-2 hours.
  • the aqueous layer was extracted with methyl tert butyl ethyl and solvent was removed to obtain the crude compound (I, 90% yield, GC purity: 93%) and purified by distillation at 80 °C to 90°C under vacuum to obtain the pure compound (I, 70% yield, HPLC purity: 99%).

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to an improved process for the preparation of 3,5-Dichloro-2,2,2-Trifluoroacetophenone of formula (I). The present invention further provides an improved process for the preparation of Fluralaner using 3,5-dichloro-2,2,2-trifluoroacetophenone of formula (I) obtained by a process described herein.

Description

“PROCESS FOR THE PREPARATION OF 3,5 -DICHLORO -2,2,2-
TRIFLUORO ACETOPHENONE”
RELATED APPLICATION
This application claims the benefit to Indian Provisional Application No. 202021021840, filed on May 25, 2020, the contents of which are incorporated by reference herein.
FIELD OF THE INVENTION
The present invention relates to an improved process for the preparation of intermediate 3,5- dichloro-2,2,2-trifluoroacetophenone of formula (I). The present invention further provides an improved process for the preparation of Fluralaner using 3,5-dichloro-2,2,2- trifluoroacetophenone of formula (I) obtained by a process described herein.
Figure imgf000002_0001
BACKGROUND OF THE INVENTION
The 3,5-dichloro-2,2,2-trifluoroacetophenone is a key intermediate for preparing veterinary APIs such as Fluralaner, Lotilaner, Afoxolaner. The 3,5-dichloro-2,2,2-trifluoroacetophenone is disclosed in a Journal of Physical Organic Chemistry ,(1989), Vol.2 (4), Pg.363-366, wherein it is synthesized from corresponding aryl halides via. Grignard reaction with trifluoroacetic anhydride at lower temperature (-70°C).
The Chinese patent application no. CN107353189; (henceforth ‘189) discloses a method for producing 3,5-dichloro-2,2,2-trifluoroacetophenone by reacting 3,5-dichlorobromobenzene with unstable trifluoroacetic anhydride in presence of expensive tert-butyllithium at -78°C. The above reaction not only involves expensive reagents but also drastic reaction conditions and result into low reaction yield (41%). The Ί89 patent application also disclosed the use of 3,5-dichlorobromobenzene and 1 -trifluoroacetyl piperidine in presence of tert-butyl lithium at -78°C for isolation of 3,5-dichloro-2,2,2-trifluoroacetophenone after high vacuum distillation resulting in low chemical yield (37%). The above reaction involved costly reagents, multiple purifications including high vacuum distillation, thus increases overall cost.
International (PCT) publication no. W02010/125130 (henceforth ‘130) discloses a method for producing a 3,5-dichloro-2,2,2-trifluoroacetophenone by reacting 3,5- dichlorobromobenzene and ethyl trifluoroacetate in presence of diisobutylaluminium hydride, magnesium metal at 0°C. The above reaction involves expensive reagents to produce low reaction yield (36%) with low purity (70%). It requires further purification and therefore the overall production cost increases.
The prior-art process(es) involve one or more process steps and/or reasons where the overall production cost increases in the production of an intermediate 3,5-dichloro-2,2,2- trifluoroacetophenone and consequently of Fluralaner.
The application of intermediate of formula (I) for preparation of fluralaner is as shown below.
Figure imgf000003_0001
Wherein T and Y each independently represent a substituted aryl or a substituted heteroaryl, X represents a hydrogen atom or a halogen atom.
The inventors of instant invention have developed an improved process for the preparation of 3,5-dichloro-2,2,2-trifluoroacetophenone to overcome the limitations of the prior arts in cost effective and industrially convenient way in high yield (70%) in less cycle time with greater chemical purity (99%). The instant two-step process performed on industrial scale by using commercially available key raw materials such as piperidine and 3,5-dichloroaniline. The instant process involve the simple reactions such as Sandmeyer reaction for preparation of 3.5-dichlorobromobenzene from 3,5-dichloroaniline and coupling of 3,5- dichlorobromobenzene with 1 -trifluoroacetyl piperidine in presence of Grignard reagent to obtain 3,5-dichloro-2,2,2-trifluoroacetophenone (I), which is further utilized for the preparation of Fluralaner as disclosed in Nissan’s PCT application WO 2013/021949 A1.
OBJECTIVES OF THE INVENTION
The main objective of the present invention is to provide an improved process for the preparation of a 3,5-dichloro-2,2,2-trifluoroacetophenone formula (I) using key raw materials piperidine and 3,5-dichloroaniline.
Another objective of the present invention is to provide a process for preparation of 3,5- dichloro-2,2,2-trifluoroacetophenoneformula (I) by reacting compound of formula (II) and compound of formula (IV).
Yet another objective of the present invention is to provide an improved process for the preparation of Fluralaner by using 3,5-dichloro-2,2,2-trifluoroacetophenone formula (I) which is obtained by a process of an instant invention.
SUMMARY OF THE INVENTION
In one aspect of the present invention provides an improved process for the preparation of
3.5-dichloro-2,2,2-trifluoroacetophenone of formula (I) which comprises the steps of:
Figure imgf000004_0001
a) reacting piperidine andethyl triflu oroacetate to obtain compound of formula (II);
Figure imgf000004_0002
b) obtaining compound of formula (I) by reacting compound of formula (II) and compound of formula (IV) with Grignard reagent in presence of solvent, wherein compound of formula (IV) is obtained by preparing a diazonium salt of compound formula (III) in presence of copper halide or potassium halide, acid and aqueous hydrogen bromide;
Figure imgf000005_0001
c) optionally, purifying compound of formula (I).
The above process is illustrated in the following general synthetic scheme:
Figure imgf000005_0002
In another aspect of the present invention provides an improved process for the preparation of Fluralaner using 3,5-dichloro-2,2,2-trifluoroacetophenone of formula (I) obtained by a process described herein, where the process for preparation of Fluralaner is followed by a skilled person as illustrated in WO 2013021949. DETAILED DESCRIPTION OF THE INVENTION
The present invention now will be described more fully hereinafter. As used herein, the terms "comprises," "comprising," "includes," "including," "has," "having," "contains" or "containing," or any other variation thereof, are intended to cover a non-exclusive inclusion. For example, a composition, a mixture, process, method, article, or apparatus that comprises a list of elements is not necessarily limited to only those elements but may include other elements not expressly listed or inherent to such composition, mixture, process, method, article, or apparatus. Further, unless expressly stated to the contrary, "or" refers to an inclusive or and not to an exclusive. As used in the specification, and in the appended claims, indefinite articles "a" and "an" preceding an element or component of the invention are intended to be nonrestrictive regarding the number of instances (i.e. occurrences) of the element or component. Therefore "a" or "an" should be read to include one or at least one, and the singular word form of the element or component also includes the plural unless the number is obviously meant to be singular indicates otherwise.
The term ‘solvent’ used herein, refers to the single solvent or mixture of solvents.
In accordance with the objectives, wherein the present invention provides the process for preparation of 3,5-dichloro-2,2,2-trifluoroacetophenone of formula (I), which comprises the step(a) of reacting a piperidine and ethyl triflu oroacetate to obtain compound of formula (II) without using any solvent and reagent (neat reaction). In another embodiment of the present invention, wherein the step (a) is performed at temperature 25 °C to 90°C and for 4-6 hours.
In another embodiment of the present invention, wherein compound of step (a) is obtained by distillation under vacuum of 15 to20 Torr at temperature 80°C to90°C.
In accordance with the objectives, wherein compound of formula (I) instep (b) is obtained by reacting a compound of formula (II) with compound of formula (IV) in presence of Grignard reagent in solvent such as tetrahydrofuran; wherein the Grignard reagent is prepared by using suitable alkyl magnesium halide in presence of suitable initiator in suitable solvent or mixture of solvents thereof.
In another embodiment of the present invention, wherein suitable alkyl magnesium halide is prepared by reacting alkyl halide with magnesium metal in suitable solvents at 10°C to 30°C.
In another embodiment of the present invention, wherein suitable alkyl halide is selected from isopropyl bromide, isopropyl chloride, methyl bromide and the like.
In another embodiment of the present invention, wherein suitable initiator is Iodine.
In another embodiment of the present invention, wherein suitable solvents of step (b) is ethereal solvent and hydrocarbon solvent.
In another embodiment of the present invention, wherein ethereal solvent is selected from tetrahydrofuran, diethyl ether, dibutyl ether, 2 -methyl tetrahydrofuran, tert -butyl methyl ether and the like; preferably tetrahydrofuran.
In another embodiment of the present invention, wherein hydrocarbon solvent is selected from toluene, hexane, and the like.
In another embodiment of the present invention, wherein the compound of formula (IV) is obtained from 3,5-dichloroaniline of formula (III) by Sandmeyer reaction in presence of suitable copper halide or potassium halide in aqueous hydrogen bromide with diazonium salt of 3,5-dichloroaniline in presence of suitable solvent..
In another embodiment of the present invention, wherein diazonium salt is prepared by reacting 3,5-dichloroaniline of formula (III) with sodium nitrite in a suitable acid; wherein suitable acid is selected from hydrobromic acid, hydrochloric acid, concentrated sulfuric acid, acetic acid and the like; preferably hydrochloric acid.
In another embodiment of the present invention, wherein suitable solvent used for preparation of diazonium salt is selected from water, acetonitrile, polyethylene glycol and the like; preferably water.
In another embodiment of the present invention, wherein suitable Copper halide is selected from Copper (I) bromide, Copper (I) chloride, Copper (I) iodide and suitable potassium halide is Potassium Iodide.
In another embodiment of the present invention, wherein the preparation of compound (IV) and compound (I) is performed at temperature 10°C to 90° C for 2-6 hours.
In another embodiment of the present invention, wherein the overall reaction time to obtain compound (I) is 20-24 hours.
In another embodiment of the present invention, wherein in step (c) pure compound (I) is obtained by high vacuum distillation using vacuum of 10-15 torr at 80°C to 90°C.
In another embodiment of the present invention, wherein the preparation of a compound of formula (II) and compound (IV) is performed in an in-situ manner.
In still another embodiment of the present invention wherein the one or more steps from (a) to (b) of the instant invention is performed in in-situ manner.
In another embodiment of the present invention, wherein all the crude compound may be used as such or may be purified by distillation or any other purification technique well understood by those skilled in the art.
The compound 3,5-dichloro-2,2,2-trifluoroacetophenone of formula (I) obtained by the process described herein is further used for the preparation of Fluralaner.
The preparation of the starting materials and reagents used in the present invention are well known in prior art. The invention is further illustrated by the following examples, which should not be construed to limit the scope of the invention in anyway.
EXPERIMENTAL
Example 1: Preparation of 1-trifluoroacetyl piperidine (II)
The ethyl trifluoroacetate (1.0 to 1.2eq) was added into piperidine (l.Oeq) at 20°C to 30°C for 1-2 hours. The reaction mixture was heated at 75°C to 85°C and stirred for 3-4 hours. After completion of reaction, the reaction mixture was kept for simple distillation at 90 °C to 100°C for 3-4 hours and further distilled under vacuum of at 80°C to 90°Cto obtain the compound II (90% yield, GC purity: 99.9%).
Example 2: Preparation of 3,5-dichlorobromobenzene (IV)
To 3,5-dichloroaniline (l.Oeq), acetonitrile (IV) was charged and stirred at 20°C to 30°C for 15 min. Water (2V) and aqueous hydrobromic acid (3V) were added at 25°C to 35°C. The reaction mixture was cooled to 0°C to 5°C and aqueous sodium nitrite solution (70.26 g, 1.1 eq) was added slowly at 0°C to 5°C within 1-3 hours. The reaction mixture was stirred at 0°C to 5°C for 1 hour. The solution of Copper bromide (0.4 eq) in 48% hydrobromic acid (4.0eq) was added to reaction mixture at0°C to 15°C for 1-2 hours and the reaction temperature was raised to 20°C to 30°C and stirred for 2 hours and further heated to 70°C to 75°C for 2 hours. After completion of reaction, reaction mixture was cooled to 20°C to 30°C and quenched by adding water. The aqueous layer was extracted with dichloromethane and combined organic layer was washed with aqueous sodium bicarbonate and brine solution. The solvent was removed under vacuum to obtain the crude compound IV and the pure compound is obtained by high vacuum distillation (72% yield, HPLC purity: 98%).
Example 3: 3,5-dichloro-2,2,2-trifluoroacetophenone (I)
The magnesium turning (1.0 to 1.4 eq), tetrahydrofuran (IV) and Iodine (0.1 to0.4eq) were charged into a round bottom flask and stirred. To the reaction mixture a solution of isopropyl bromide (1 to 1.4 eq) in tetrahydrofuran (3V) was added and stirred at 20°C to 30°C for 1-2 hours. The reaction mixture was cooled to 0°C to 5°C and a solution of 3,5- dichlorobromobenzene (IV, l.Oeq) in tetrahydrofuran (2V) was added. The reaction temperature was raised to 0°C to 30°C and stirred for 1 hour. The reaction mixture was cooled to 0°C to 5°C and 1-trifluoroacetyl piperidine (II) was added. The reaction temperature was raised to 20°C to 30°C and stirred for 1-2 hours. After completion of reaction the reaction mixture was cooled to 0°C to 5°C and quenched by adding into aqueous hydrochloric acid. The reaction mass temperature was raised to 20°C to 30°C and stirred for 1-2 hours. The aqueous layer was extracted with methyl tert butyl ethyl and solvent was removed to obtain the crude compound (I, 90% yield, GC purity: 93%) and purified by distillation at 80 °C to 90°C under vacuum to obtain the pure compound (I, 70% yield, HPLC purity: 99%).

Claims

CLAIM:
1. A process for the preparation of 3,5-dichloro-2,2,2-trifluoroacetophenone of formula (I) which comprises the steps of:
Figure imgf000011_0001
a) reacting piperidine and ethyl trifluoro acetate to obtain compound of formula (II);
Figure imgf000011_0002
b) obtaining compound of formula (I) by reacting compound of formula (II) and compound of formula (IV) with Grignard reagent in presence of solvent, wherein compound of formula (IV) is obtained by preparing a diazonium salt of compound formula (III) in presence of copper halide or potassium halide, acid and aqueous hydrogen bromide;
Figure imgf000011_0003
c) optionally, purifying compound of formula (I).
2. The process as claimed in claim 1, wherein the step (a) involve neat reaction conditions which is carried out at temperature between 10°C to 90°C for 2-6 hours.
3. The process as claimed in claim 1, wherein Grignard reagent in step (b) is prepared using alkyl magnesium halide in presence of initiator insolvent at temperature between 10°C to 90°C.
4. The process as claimed in claim 3, wherein alkyl magnesium halide is prepared by reacting alkyl halide such as isopropyl bromide, isopropyl chloride and methyl bromide; with magnesium metal in solvent.
5. The process as claimed in claim 3, wherein said initiator is Iodine.
6. The process as claimed in claim 1, wherein the solvent in step (b) used for Grignard reaction is selected from tetrahydrofuran, diethyl ether, dibutyl ether, 2-methyl tetrahydrofuran, tert-butyl methyl ether, toluene, hexane; and for diazotization is selected from water, acetonitrile, polyethylene glycol.
7. The process as claimed in claim 1, wherein diazonium salt is prepared by reacting compound formula (III) with sodium nitrite in an acid; where acid is selected from hydrobromic acid, hydrochloric acid, concentrated sulfuric acid and acetic acid.
8. The process as claimed in claim 1, wherein Copper halide is selected from Copper (I) bromide, Copper (I) chloride, Copper (I) iodide, and potassium halide is Potassium Iodide.
9. The process as claimed in claim 1, wherein the step (c) is carried out by high vacuum distillation using vacuum of 10 to 15 Torr at 80°C to 90° C.
10. The process as claimed in claim 1, wherein compound of formula (I) obtained by cited process is used for preparation of Fluralaner.
PCT/IB2021/054467 2020-05-25 2021-05-23 Process for the preparation of 3,5-dichloro-2,2,2-trifluoroacetophenone WO2021240331A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN202021021840 2020-05-25
IN202021021840 2020-05-25

Publications (1)

Publication Number Publication Date
WO2021240331A1 true WO2021240331A1 (en) 2021-12-02

Family

ID=78744246

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2021/054467 WO2021240331A1 (en) 2020-05-25 2021-05-23 Process for the preparation of 3,5-dichloro-2,2,2-trifluoroacetophenone

Country Status (1)

Country Link
WO (1) WO2021240331A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107353189A (en) * 2017-07-06 2017-11-17 荆门医药工业技术研究院 Prepare 3,5 dichloro a（Trifluoromethyl）The method of styrene
WO2018009751A1 (en) * 2016-07-08 2018-01-11 Avista Pharma Solutions, Inc. Antiparasitic compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018009751A1 (en) * 2016-07-08 2018-01-11 Avista Pharma Solutions, Inc. Antiparasitic compounds
CN107353189A (en) * 2017-07-06 2017-11-17 荆门医药工业技术研究院 Prepare 3,5 dichloro a（Trifluoromethyl）The method of styrene

Similar Documents

Publication Publication Date Title
JPH0717533B2 (en) Method for producing (2,2) -paracyclophane and derivatives thereof
WO2003042139A1 (en) Process for preparation of dihalogenoadamantanes
KR20100029332A (en) New preparation of hydroxychloroquine
KR101583851B1 (en) Method for producing 3-methyl-2-thiophenecarboxylic acid
WO2021240331A1 (en) Process for the preparation of 3,5-dichloro-2,2,2-trifluoroacetophenone
EP3196183B1 (en) Method for producing 2'-trifluoromethyl group-substituted aromatic ketone
JP2003335735A (en) Method for producing perfluoroisopropylanilines
US11384041B2 (en) Process for preparing an alkoxymethyl alkynyl ether compound having a terminal triple bond
JP4667593B2 (en) Process for producing 2-alkyl-2-adamantyl (meth) acrylates
JP7018327B2 (en) Method for producing benzaldehyde derivative
CN107602337B (en) Preparation method of 1,4-dicyano-2-butene
JP4649733B2 (en) Method for producing acetophenone compound containing trifluoromethyl group
JP4481589B2 (en) Method for producing bisphosphine
CN115260103B (en) Preparation method of 4,5-dihalogen-1- (difluoromethyl) -1H-imidazole
JPH0480910B2 (en)
JP7183509B2 (en) Method for producing alicyclic acrylic derivative
JP4329304B2 (en) 1,4-Dibromobutane and process for producing the same
WO1999058485A1 (en) A process for the synthesis of alkoxyalkyl (trifluoromethylphenyl) methanones
JP4435447B2 (en) Method for producing methoxymethyltriarylphosphonium chloride
JP3787821B2 (en) Method for producing benzamidoxime compound
KR20240069893A (en) Novel method for preparing high purity 9-phenylcarbazole
JP4662649B2 (en) Novel phosphine compounds
WO2005014519A1 (en) Process for the preparation of geminal difluoroalkanes
WO2011152501A1 (en) Production method for long-chain, saturated, aliphatic, primary alcohols
JP4243397B2 (en) Novel unsaturated secondary alcohol and process for producing the same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21814239

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21814239

Country of ref document: EP

Kind code of ref document: A1